Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
186.80    0.20 (0.11%)
Bid:
186.40
Ask:
186.60
Spread: 0.20 (0.107%)
Market Cap: £1.88b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Pre Stabilisation Notice

13 Nov 2023 14:28

RNS Number : 2763T
HSBC Bank plc
13 November 2023
 

13th November 2023

 

B&M European Value Retail S.A.

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

B&M European Value Retail S.A.

Guarantor (if any):

na

Aggregate nominal amount:

GBP 250,000,000

Description:

Fixed due 2030 nc 3

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc

Stabilisation period expected to start on:

14th November 2023

Stabilisation period expected to end no later than:

22nd December 2023

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAZZMMMDFDGFZM
Date   Source Headline
20th Aug 20259:00 amRNSDirector/PDMR Shareholding
14th Aug 20255:30 pmRNSDirector/PDMR Exercise of Share Options
1st Aug 202510:00 amRNSDirector/PDMR Shareholding
30th Jul 20259:00 amRNSDirector/PDMR Shareholding
23rd Jul 20259:01 amRNSResult of EGM
23rd Jul 20259:00 amRNSResult of AGM 22 July 2025
22nd Jul 20254:00 pmRNSTR1 Major Shareholdings in Company
21st Jul 20258:00 amRNSBlock Listing Application
16th Jul 20256:00 pmRNSTR1: Major Shareholding Notification
15th Jul 20257:00 amRNSPositive Quarterly LFL Trading Performance
14th Jul 20255:30 pmRNSBlock Listing Six Monthly Return
3rd Jul 20259:00 amRNSTR1: Major Holdings in Company
3rd Jul 20259:00 amRNSTR1: Major Holdings in Company
27th Jun 202511:00 amRNSTR1: Major Holdings in Company
24th Jun 202510:00 amRNSNotice of FY26 Q1 Trading Statement
19th Jun 20254:30 pmRNSDirector Purchase of Shares
19th Jun 20257:00 amRNSNotice of EGM to approve Migration
19th Jun 20257:00 amRNSPublication of Annual Report and Notice of AGM
17th Jun 20257:00 amRNSCEO Purchase of Shares
12th Jun 20255:00 pmRNSDirector/PDMR Purchase of Shares
12th Jun 202510:30 amRNSDirector Share Options
4th Jun 20257:00 amRNSFY25 Preliminary Results
2nd Jun 20256:24 pmRNSTotal Voting Rights
19th May 20255:30 pmRNSTR1: Major Holdings in Company
15th May 20257:00 amRNSAppointment of Tjeerd Jegen as CEO
30th Apr 20257:00 amRNSDirectorate Change
15th Apr 20257:00 amRNSFY25 Post Close Trading Statement
11th Apr 20259:00 amRNSTR1- Major Shareholding Notification
8th Apr 202511:15 amRNSTR1- Major Shareholding Notification
3rd Apr 20256:15 pmRNSTotal Voting Rights - Correction
1st Apr 202512:30 pmRNSTotal Voting Rights
27th Mar 20254:00 pmRNSTR1 - Major Shareholding Notification
24th Mar 202512:00 pmRNSNotice of FY25 Post Close Trading Statement
27th Feb 20257:45 amRNSDirector/PDMR Purchase of Shares
24th Feb 20257:00 amRNSDirectorate Change and Update on FY25 Guidance
19th Feb 20259:00 amRNSTR1 Major Shareholding Notification
7th Feb 20259:00 amRNSTR1 Major Shareholding Notification
3rd Feb 20255:00 pmRNSTR1 Major Shareholding Notification
30th Jan 20255:30 pmRNSTR1 Major Shareholding Notification
24th Jan 202511:00 amRNSTR1 Major Shareholding Notification
20th Jan 202510:45 amRNSResult of OGM
14th Jan 20255:33 pmRNSBlock Listing Six Monthly Return
13th Jan 20254:00 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNS3rd Quarter Trading Update
18th Dec 20248:31 amRNSNotice of Ordinary General Meeting
17th Dec 20249:15 amRNSBoard Appointment
10th Dec 202410:30 amRNSTiming of Announcement of Q3 Trading Statement
9th Dec 20244:00 pmRNSDirector Purchase of Shares
22nd Nov 20244:02 pmRNSDirector Exercise of Share Options
22nd Nov 20244:00 pmRNSDirector Purchase of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.